Literature DB >> 11312236

Should we screen for type 2 diabetes? Evaluation against National Screening Committee criteria.

N J Wareham1, S J Griffin.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11312236      PMCID： PMC1120142          DOI： 10.1136/bmj.322.7292.986

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  23 in total

1.  Screening for Type 2 diabetes mellitus: a decision analytic approach.

Authors:  E C Goyder; L M Irwig
Journal:  Diabet Med       Date:  2000-06       Impact factor: 4.359

2.  Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study.

Authors:  P Gaede; P Vedel; H H Parving; O Pedersen
Journal:  Lancet       Date:  1999-02-20       Impact factor: 79.321

3.  Evidence of bimodality of two hour plasma glucose concentrations in Mexican Americans: results from the San Antonio Heart study.

Authors:  M Rosenthal; C A McMahan; M P Stern; C W Eifler; S M Haffner; H P Hazuda; L J Franco
Journal:  J Chronic Dis       Date:  1985

4.  Psychological impact of predicting individuals' risks of illness: a systematic review.

Authors:  C Shaw; K Abrams; T M Marteau
Journal:  Soc Sci Med       Date:  1999-12       Impact factor: 4.634

5.  UK Prospective Diabetes Study 6. Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors.

Authors: 
Journal:  Diabetes Res       Date:  1990-01

6.  The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years.

Authors:  M Coutinho; H C Gerstein; Y Wang; S Yusuf
Journal:  Diabetes Care       Date:  1999-02       Impact factor: 19.112

7.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

Authors: 
Journal:  Lancet       Date:  2000-01-22       Impact factor: 79.321

8.  Diabetes risk score: towards earlier detection of type 2 diabetes in general practice.

Authors:  S J Griffin; P S Little; C N Hales; A L Kinmonth; N J Wareham
Journal:  Diabetes Metab Res Rev       Date:  2000 May-Jun       Impact factor: 4.876

9.  Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis.

Authors:  M I Harris; R Klein; T A Welborn; M W Knuiman
Journal:  Diabetes Care       Date:  1992-07       Impact factor: 19.112

10.  Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes.

Authors:  D R McCance; R L Hanson; M A Charles; L T Jacobsson; D J Pettitt; P H Bennett; W C Knowler
Journal:  BMJ       Date:  1994-05-21
View more
  39 in total

1.  Screening for type 2 diabetes. Undiagnosed diabetes must be detected.

Authors:  P Streets
Journal:  BMJ       Date:  2001-08-25

2.  Sequential screening for diabetes--evaluation of a campaign in Swiss community pharmacies.

Authors:  Kurt E Hersberger; Andrea Botomino; Maxime Mancini; Rudolf Bruppacher
Journal:  Pharm World Sci       Date:  2006-09-27

3.  Screening for diabetes.

Authors:  Ronald P Stolk
Journal:  BMJ       Date:  2007-08-30

4.  Screening for diabetes.

Authors:  Beverley Balkau
Journal:  Diabetes Care       Date:  2008-05       Impact factor: 19.112

5.  Yield of opportunistic targeted screening for type 2 diabetes in primary care: the diabscreen study.

Authors:  Erwin P Klein Woolthuis; Wim J C de Grauw; Willem H E M van Gerwen; Henk J M van den Hoogen; Eloy H van de Lisdonk; Job F M Metsemakers; Chris van Weel
Journal:  Ann Fam Med       Date:  2009 Sep-Oct       Impact factor: 5.166

6.  Screening and identifying diabetes in optometric practice: a prospective study.

Authors:  Jennifer H Howse; Steve Jones; A Pali S Hungin
Journal:  Br J Gen Pract       Date:  2011-07       Impact factor: 5.386

7.  Long-term effect of population screening for diabetes on cardiovascular morbidity, self-rated health, and health behavior.

Authors:  Justin B Echouffo-Tcheugui; Rebecca K Simmons; A Toby Prevost; Kate M Williams; Ann-Louise Kinmonth; Nicholas J Wareham; Simon J Griffin
Journal:  Ann Fam Med       Date:  2015-03       Impact factor: 5.166

8.  Impact of an informed choice invitation on uptake of screening for diabetes in primary care (DICISION): trial protocol.

Authors:  Eleanor Mann; A Toby Prevost; Simon Griffin; Ian Kellar; Stephen Sutton; Michael Parker; Simon Sanderson; Ann Louise Kinmonth; Theresa M Marteau
Journal:  BMC Public Health       Date:  2009-02-20       Impact factor: 3.295

9.  The ADDITION-Cambridge trial protocol: a cluster -- randomised controlled trial of screening for type 2 diabetes and intensive treatment for screen-detected patients.

Authors:  Justin B Echouffo-Tcheugui; Rebecca K Simmons; Kate M Williams; Roslyn S Barling; A Toby Prevost; Ann Louise Kinmonth; Nicholas J Wareham; Simon J Griffin
Journal:  BMC Public Health       Date:  2009-05-12       Impact factor: 3.295

10.  Are people with negative diabetes screening tests falsely reassured? Parallel group cohort study embedded in the ADDITION (Cambridge) randomised controlled trial.

Authors:  Charlotte A M Paddison; Helen C Eborall; Stephen Sutton; David P French; Joana Vasconcelos; A Toby Prevost; Ann-Louise Kinmonth; Simon J Griffin
Journal:  BMJ       Date:  2009-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.